(Hypertension. 1996;27:613-618.)
© 1996 American Heart Association, Inc.
Articles |
From the Department of Physiology and Biophysics, the University of Mississippi Medical Center, Jackson.
Correspondence to Joey P. Granger, PhD, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 North State St, Jackson, MS 39216-4505. E-mail jpg@fiona.umsmed.edu.
Abstract Recent studies suggest that enhanced renal sympathetic nervous activity plays an important role in mediating the renal hemodynamic and electrolyte excretion changes associated with acute inhibition of NO synthesis. The purpose of this study was to determine the importance of renal nerves in mediating the long-term hypertensive and renal actions of NO synthesis blockade. To achieve this goal, we infused NG-nitro-L-arginine methyl ester (L-NAME) at a rate of 25 µg/kg per minute for 2 weeks in control dogs and in bilaterally renal-denervated dogs. NO synthesis blockade in control dogs increased arterial pressure by 18%, from 94±3 to 111±4 mm Hg, and decreased heart rate from 74±4 to 57±4 beats per minute (bpm). L-NAME also decreased renal plasma flow from 195±18 to 166±18 mL/min while having no effect on glomerular filtration rate (67±7 versus 63±6 mL/min). In the renal-denervated dogs, inhibition of NO synthesis increased arterial pressure by 14%, from 92±4 to 105±5 mm Hg, and decreased heart rate from 80±4 to 65±5 bpm. Renal plasma flow in this group decreased from 195±20 to 165±20 mL/min, whereas glomerular filtration rate remained unchanged (66±6 versus 64±6 mL/min). In addition, renal excretion of sodium and water in response to L-NAME was similar in each group. The results of this study indicate that the long-term hypertensive and renal effects of NO synthesis inhibition in the dog are not dependent on activation of the renal sympathetic nervous system.
Key Words: endothelium renal hemodynamics kidney nitric oxide dog
This article has been cited by other articles:
![]() |
R. Ramchandra, C. J. Barrett, S.-J. Guild, F. McBryde, and S. C. Malpas Role of renal sympathetic nerve activity in hypertension induced by chronic nitric oxide inhibition Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1479 - R1485. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Gaballa, T. E. Raya, C. A. Hoover, and S. Goldman Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction Cardiovasc Res, June 1, 1999; 42(3): 627 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zatz and C. Baylis Chronic Nitric Oxide Inhibition Model Six Years On Hypertension, December 1, 1998; 32(6): 958 - 964. [Full Text] [PDF] |
||||
![]() |
W. Wang Cardiac sympathetic afferent stimulation by bradykinin in heart failure: role of NO and prostaglandins Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H783 - H788. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Gonzalez, M. T. Llinas, E. Nava, L. Ghiadoni, and F. J. Salazar Role of Nitric Oxide and Prostaglandins in the Long-term Control of Renal Function Hypertension, July 1, 1998; 32(1): 33 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Reinhart, T. E. Lohmeier, and H. L. Mizelle Temporal Influence of the Renal Nerves on Renal Excretory Function During Chronic Inhibition of Nitric Oxide Synthesis Hypertension, January 1, 1997; 29(1): 199 - 204. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |